Baudax Bio Inc reports results for the quarter ended in June - Earnings Summary

Baudax Bio

16/08/2023 13:38

* Baudax Bio Inc  BXRX.OQ  reported a quarterly adjusted
loss of
$1.52​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of $2.04 per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Baudax Bio Inc's reported EPS for the quarter was a loss
of
$1.51​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Baudax Bio Inc shares had fallen by 50.8% this quarter and
lost 81.9% so far this year.
    * The company reported a quarterly loss of $7.38 million.
    * Wall Street's median 12-month price target for Baudax Bio
Inc is
$24.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 16 at 12:38 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -2.04          -1.52          Beat
 Mar. 31 2023      5.75           -3.91          Missed
 Dec. 31 2022      -9.76          -12.33         Missed
 Sep. 30 2022      -21.20         -26.40         Missed